108985
论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
- 3.4 Breast Cancer (Dove Med Press)
- 3.2 Clin Epidemiol
- 2.6 Cancer Manag Res
- 2.9 Infect Drug Resist
- 3.7 Clin Interv Aging
- 5.1 Drug Des Dev Ther
- 3.1 Int J Chronic Obstr
- 6.6 Int J Nanomed
- 2.6 Int J Women's Health
- 2.9 Neuropsych Dis Treat
- 2.8 OncoTargets Ther
- 2.0 Patient Prefer Adher
- 2.2 Ther Clin Risk Manag
- 2.5 J Pain Res
- 3.0 Diabet Metab Synd Ob
- 3.2 Psychol Res Behav Ma
- 3.4 Nat Sci Sleep
- 1.8 Pharmgenomics Pers Med
- 2.0 Risk Manag Healthc Policy
- 4.1 J Inflamm Res
- 2.0 Int J Gen Med
- 3.4 J Hepatocell Carcinoma
- 3.0 J Asthma Allergy
- 2.2 Clin Cosmet Investig Dermatol
- 2.4 J Multidiscip Healthc
已发表论文
线粒体功能障碍在脓毒症相关急性肾损伤中的作用：综述性文章
Authors Liu J, Zheng J, Xu Y, Jiang Y
Received 15 July 2025
Accepted for publication 29 September 2025
Published 24 October 2025 Volume 2025:19 Pages 9545—9558
DOI https://doi.org/10.2147/DDDT.S553838
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Editor who approved publication: Professor Tamer Ibrahim
Junfei Liu, Jingmin Zheng, Yinghe Xu, Yongpo Jiang
Department of Critical Care Medicine, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Taizhou, 317000, People’s Republic of China
Correspondence: Yinghe Xu, Email xuyh@enzemed.com Yongpo Jiang, Email jyongpo8@163.com
Abstract: Sepsis-associated acute kidney injury (SA-AKI) is one of the most frequent complications of sepsis and one of the leading causes of acute kidney injury (AKI), posing a significant threat to patient survival. The pathogenesis of SA-AKI has been linked to mitochondrial dysfunction, according to emerging evidence. Mitochondria serve as the primary energy-producing organelles in cells, and mitochondrial dysfunction can result in insufficient renal energy supply, oxidative stress, and inflammatory responses, all of which can both initiate and exacerbate SA-AKI. Thus, elucidating the role of mitochondrial dysfunction in SA-AKI is of critical importance. Starting from the fundamental mechanisms of mitochondrial dysfunction, this review draws upon more than 130 relevant publications through August 2025, comprehensively summarizes the role of mitochondrial dysfunction in the pathophysiological processes of SA-AKI and the drugs for treating SA-AKI through the improvement of mitochondrial function, while also discussing in detail the potential therapeutic applications of several well-characterized therapeutic targets in SA-AKI, providing important insights into the diagnosis and treatment of this disease.
Keywords: sepsis, SA-AKI, mitochondrial dysfunction, therapeutic
Department of Critical Care Medicine, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Taizhou, 317000, People’s Republic of China
Correspondence: Yinghe Xu, Email xuyh@enzemed.com Yongpo Jiang, Email jyongpo8@163.com
Abstract: Sepsis-associated acute kidney injury (SA-AKI) is one of the most frequent complications of sepsis and one of the leading causes of acute kidney injury (AKI), posing a significant threat to patient survival. The pathogenesis of SA-AKI has been linked to mitochondrial dysfunction, according to emerging evidence. Mitochondria serve as the primary energy-producing organelles in cells, and mitochondrial dysfunction can result in insufficient renal energy supply, oxidative stress, and inflammatory responses, all of which can both initiate and exacerbate SA-AKI. Thus, elucidating the role of mitochondrial dysfunction in SA-AKI is of critical importance. Starting from the fundamental mechanisms of mitochondrial dysfunction, this review draws upon more than 130 relevant publications through August 2025, comprehensively summarizes the role of mitochondrial dysfunction in the pathophysiological processes of SA-AKI and the drugs for treating SA-AKI through the improvement of mitochondrial function, while also discussing in detail the potential therapeutic applications of several well-characterized therapeutic targets in SA-AKI, providing important insights into the diagnosis and treatment of this disease.
Keywords: sepsis, SA-AKI, mitochondrial dysfunction, therapeutic